

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.16952827 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.74999814 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.74999814 |
| 4 | negative regulation of cell killing (GO:0031342) | 6.16434015 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.16434015 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.05797527 |
| 7 | negative T cell selection (GO:0043383) | 5.88823522 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.76431842 |
| 9 | negative thymic T cell selection (GO:0045060) | 5.74567338 |
| 10 | positive thymic T cell selection (GO:0045059) | 5.47846678 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.39969664 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 5.35550129 |
| 13 | response to interleukin-15 (GO:0070672) | 5.29328715 |
| 14 | cellular response to interleukin-15 (GO:0071350) | 5.10727692 |
| 15 | thymic T cell selection (GO:0045061) | 4.94369852 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.93658979 |
| 17 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.84229410 |
| 18 | positive T cell selection (GO:0043368) | 4.80482543 |
| 19 | T cell selection (GO:0045058) | 4.65156128 |
| 20 | leukocyte aggregation (GO:0070486) | 4.63507885 |
| 21 | interferon-gamma production (GO:0032609) | 4.61686107 |
| 22 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.41182876 |
| 23 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.40902275 |
| 24 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.31877630 |
| 25 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.16108011 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.02441275 |
| 27 | T cell receptor signaling pathway (GO:0050852) | 3.99646062 |
| 28 | regulation of T cell tolerance induction (GO:0002664) | 3.96348321 |
| 29 | T cell costimulation (GO:0031295) | 3.95593560 |
| 30 | lymphocyte costimulation (GO:0031294) | 3.92097684 |
| 31 | T cell migration (GO:0072678) | 3.90934587 |
| 32 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.86066476 |
| 33 | activated T cell proliferation (GO:0050798) | 3.84541467 |
| 34 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.73292712 |
| 35 | regulation of response to interferon-gamma (GO:0060330) | 3.72834628 |
| 36 | detection of bacterium (GO:0016045) | 3.72692428 |
| 37 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.72338340 |
| 38 | detection of other organism (GO:0098543) | 3.71443742 |
| 39 | ribosomal small subunit assembly (GO:0000028) | 3.70188881 |
| 40 | response to type I interferon (GO:0034340) | 3.69965458 |
| 41 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.69224932 |
| 42 | neutrophil activation involved in immune response (GO:0002283) | 3.68721444 |
| 43 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.67003244 |
| 44 | negative regulation of interleukin-12 production (GO:0032695) | 3.66578612 |
| 45 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.65981637 |
| 46 | cellular response to type I interferon (GO:0071357) | 3.61900693 |
| 47 | type I interferon signaling pathway (GO:0060337) | 3.61900693 |
| 48 | regulation of regulatory T cell differentiation (GO:0045589) | 3.60507555 |
| 49 | negative regulation of T cell mediated immunity (GO:0002710) | 3.59124682 |
| 50 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.57945534 |
| 51 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.53028521 |
| 52 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.53028521 |
| 53 | modulation by symbiont of host immune response (GO:0052553) | 3.53028521 |
| 54 | positive regulation by symbiont of host defense response (GO:0052509) | 3.53028521 |
| 55 | modulation by symbiont of host defense response (GO:0052031) | 3.53028521 |
| 56 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.53028521 |
| 57 | positive regulation of tolerance induction (GO:0002645) | 3.52490201 |
| 58 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.45126453 |
| 59 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.45126453 |
| 60 | lymph node development (GO:0048535) | 3.45023203 |
| 61 | immunoglobulin mediated immune response (GO:0016064) | 3.44169360 |
| 62 | tolerance induction (GO:0002507) | 3.41304105 |
| 63 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.41164533 |
| 64 | regulation of B cell differentiation (GO:0045577) | 3.41066012 |
| 65 | positive regulation of interleukin-2 production (GO:0032743) | 3.38844044 |
| 66 | positive regulation of B cell mediated immunity (GO:0002714) | 3.36144662 |
| 67 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.36144662 |
| 68 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.35642747 |
| 69 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.35642747 |
| 70 | positive regulation of humoral immune response (GO:0002922) | 3.35592308 |
| 71 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.34966546 |
| 72 | macrophage activation involved in immune response (GO:0002281) | 3.34817102 |
| 73 | NIK/NF-kappaB signaling (GO:0038061) | 3.29537299 |
| 74 | positive regulation of isotype switching (GO:0045830) | 3.29400448 |
| 75 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.28370103 |
| 76 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.27530923 |
| 77 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.24603912 |
| 78 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.24542551 |
| 79 | regulation of B cell mediated immunity (GO:0002712) | 3.23835756 |
| 80 | cellular extravasation (GO:0045123) | 3.23698667 |
| 81 | T cell homeostasis (GO:0043029) | 3.23008085 |
| 82 | neutrophil activation (GO:0042119) | 3.21893175 |
| 83 | dendritic cell chemotaxis (GO:0002407) | 3.18408602 |
| 84 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.17087043 |
| 85 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.16796159 |
| 86 | T cell differentiation (GO:0030217) | 3.16185820 |
| 87 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.16047082 |
| 88 | regulation of tolerance induction (GO:0002643) | 3.15449479 |
| 89 | B cell receptor signaling pathway (GO:0050853) | 3.12369763 |
| 90 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.12294781 |
| 91 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.12288594 |
| 92 | granulocyte activation (GO:0036230) | 3.11372007 |
| 93 | regulation of isotype switching (GO:0045191) | 3.08985571 |
| 94 | mature B cell differentiation (GO:0002335) | 3.08687164 |
| 95 | mature B cell differentiation involved in immune response (GO:0002313) | 3.08398109 |
| 96 | alpha-beta T cell activation (GO:0046631) | 3.07690581 |
| 97 | mast cell activation (GO:0045576) | 3.07147472 |
| 98 | myeloid cell activation involved in immune response (GO:0002275) | 3.06964596 |
| 99 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.05643303 |
| 100 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.01358228 |
| 101 | positive regulation of B cell differentiation (GO:0045579) | 3.00965740 |
| 102 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.00678837 |
| 103 | myeloid dendritic cell differentiation (GO:0043011) | 3.00582288 |
| 104 | myeloid dendritic cell activation (GO:0001773) | 2.99981107 |
| 105 | regulation of cell killing (GO:0031341) | 2.97541721 |
| 106 | dendritic cell migration (GO:0036336) | 2.96133213 |
| 107 | megakaryocyte development (GO:0035855) | 2.96119263 |
| 108 | T cell activation (GO:0042110) | 2.95912414 |
| 109 | lymphocyte migration (GO:0072676) | 2.95824238 |
| 110 | detection of external biotic stimulus (GO:0098581) | 2.95811657 |
| 111 | natural killer cell activation (GO:0030101) | 2.95292545 |
| 112 | respiratory burst (GO:0045730) | 2.94488628 |
| 113 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.92904862 |
| 114 | alpha-beta T cell differentiation (GO:0046632) | 2.92603991 |
| 115 | defense response to protozoan (GO:0042832) | 2.91825377 |
| 116 | regulation of alpha-beta T cell activation (GO:0046634) | 2.91655707 |
| 117 | leukocyte degranulation (GO:0043299) | 2.90803769 |
| 118 | regulation of antigen processing and presentation (GO:0002577) | 2.90162765 |
| 119 | leukocyte cell-cell adhesion (GO:0007159) | 2.88774086 |
| 120 | negative regulation of innate immune response (GO:0045824) | 2.88663090 |
| 121 | positive regulation of cell killing (GO:0031343) | 2.88284429 |
| 122 | definitive hemopoiesis (GO:0060216) | 2.88178844 |
| 123 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.87755979 |
| 124 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.85732218 |
| 125 | positive regulation of DNA recombination (GO:0045911) | 2.85294125 |
| 126 | regulation of response to tumor cell (GO:0002834) | 2.85235117 |
| 127 | positive regulation of response to tumor cell (GO:0002836) | 2.85235117 |
| 128 | positive regulation of immune response to tumor cell (GO:0002839) | 2.85235117 |
| 129 | regulation of immune response to tumor cell (GO:0002837) | 2.85235117 |
| 130 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.84123175 |
| 131 | positive regulation of antigen processing and presentation (GO:0002579) | 2.83990746 |
| 132 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.82890381 |
| 133 | positive regulation of granulocyte differentiation (GO:0030854) | 2.80694194 |
| 134 | response to protozoan (GO:0001562) | 2.80663153 |
| 135 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.78449520 |
| 136 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.77586228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.41985513 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.33602743 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.93124607 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.05359552 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.51059156 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.21974166 |
| 7 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.03078057 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.02389823 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.97497537 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.87246244 |
| 11 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.85639319 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.83242246 |
| 13 | * MYB_26560356_Chip-Seq_TH2_Human | 2.80640706 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.68015119 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.64841222 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.59424420 |
| 17 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.58725176 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.52712544 |
| 19 | * MAF_26560356_Chip-Seq_TH1_Human | 2.52323140 |
| 20 | * MYB_26560356_Chip-Seq_TH1_Human | 2.40219883 |
| 21 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.29021043 |
| 22 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.26038573 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.19910301 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.19528785 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.15903629 |
| 26 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14881911 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.14841999 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.11210995 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.10534718 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03901818 |
| 31 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96880308 |
| 32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96185224 |
| 33 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91451475 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.90988387 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.89901416 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.88929998 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82704685 |
| 38 | * MAF_26560356_Chip-Seq_TH2_Human | 1.79060483 |
| 39 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.75874163 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74097622 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.64188251 |
| 42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63360122 |
| 43 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.62405842 |
| 44 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.58102805 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57137308 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56655953 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53365601 |
| 48 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.51204310 |
| 49 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.50531097 |
| 50 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.49734406 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48701426 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.46416684 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44313068 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41974161 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41229242 |
| 56 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39809192 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39434836 |
| 58 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35814687 |
| 59 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.32000308 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27532964 |
| 61 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27308266 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26692774 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.25247711 |
| 64 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.24455787 |
| 65 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22526474 |
| 66 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22233452 |
| 67 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.20179594 |
| 68 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.19415995 |
| 69 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19051100 |
| 70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16675243 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16344136 |
| 72 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13553720 |
| 73 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10625840 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08590191 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05688623 |
| 76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.04242038 |
| 77 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.00355931 |
| 78 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00174694 |
| 79 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.99266978 |
| 80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97956437 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97662217 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97498183 |
| 83 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.97320538 |
| 84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96766604 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95791148 |
| 86 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95124229 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95067863 |
| 88 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94308878 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93353533 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89712225 |
| 91 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89349521 |
| 92 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88122842 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87309653 |
| 94 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87184120 |
| 95 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86936939 |
| 96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86529265 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86457330 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86303334 |
| 99 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.86258940 |
| 100 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.86255928 |
| 101 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84416370 |
| 102 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.83988656 |
| 103 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.83814456 |
| 104 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81960406 |
| 105 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81426184 |
| 106 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.79074104 |
| 107 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.78923772 |
| 108 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.78431802 |
| 109 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78274136 |
| 110 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.77424474 |
| 111 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77397809 |
| 112 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.77325280 |
| 113 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76757833 |
| 114 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.76739295 |
| 115 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.76068206 |
| 116 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.74487692 |
| 117 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73950622 |
| 118 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.72747320 |
| 119 | * P300_27268052_Chip-Seq_Bcells_Human | 0.72231136 |
| 120 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.72092454 |
| 121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.71804646 |
| 122 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68932576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.73026725 |
| 2 | MP0005671_abnormal_response_to | 4.03467161 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.52297953 |
| 4 | MP0000685_abnormal_immune_system | 3.52237508 |
| 5 | MP0009785_altered_susceptibility_to | 3.01550355 |
| 6 | MP0001800_abnormal_humoral_immune | 2.97773570 |
| 7 | MP0002166_altered_tumor_susceptibility | 2.87487010 |
| 8 | MP0005387_immune_system_phenotype | 2.82500400 |
| 9 | MP0001790_abnormal_immune_system | 2.82500400 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.70748624 |
| 11 | MP0003724_increased_susceptibility_to | 2.62909664 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.60913150 |
| 13 | MP0002723_abnormal_immune_serum | 2.58024611 |
| 14 | MP0001819_abnormal_immune_cell | 2.56824753 |
| 15 | MP0005025_abnormal_response_to | 2.56538420 |
| 16 | MP0001873_stomach_inflammation | 2.54880642 |
| 17 | MP0002398_abnormal_bone_marrow | 2.52753838 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.46910282 |
| 19 | MP0002396_abnormal_hematopoietic_system | 2.35784397 |
| 20 | MP0003436_decreased_susceptibility_to | 2.34511055 |
| 21 | MP0010155_abnormal_intestine_physiology | 2.32649183 |
| 22 | MP0000716_abnormal_immune_system | 2.24268943 |
| 23 | MP0002405_respiratory_system_inflammati | 2.22271785 |
| 24 | MP0002006_tumorigenesis | 2.21854740 |
| 25 | MP0003866_abnormal_defecation | 2.20704387 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.15196816 |
| 27 | MP0003300_gastrointestinal_ulcer | 2.11225918 |
| 28 | MP0002722_abnormal_immune_system | 2.07519188 |
| 29 | MP0000689_abnormal_spleen_morphology | 2.06440742 |
| 30 | MP0000703_abnormal_thymus_morphology | 2.04062844 |
| 31 | MP0004947_skin_inflammation | 1.94500522 |
| 32 | MP0002419_abnormal_innate_immunity | 1.93611216 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.91409631 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.90156157 |
| 35 | MP0002429_abnormal_blood_cell | 1.87009506 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.78332890 |
| 37 | MP0006082_CNS_inflammation | 1.72731636 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.67493928 |
| 39 | MP0004808_abnormal_hematopoietic_stem | 1.64684824 |
| 40 | MP0001853_heart_inflammation | 1.63214885 |
| 41 | MP0002933_joint_inflammation | 1.54600164 |
| 42 | MP0005075_abnormal_melanosome_morpholog | 1.46496568 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.46199380 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.45755946 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.45755946 |
| 46 | MP0000490_abnormal_crypts_of | 1.38805119 |
| 47 | MP0008260_abnormal_autophagy | 1.36920041 |
| 48 | MP0005451_abnormal_body_composition | 1.33141114 |
| 49 | MP0008469_abnormal_protein_level | 1.31499777 |
| 50 | MP0000858_altered_metastatic_potential | 1.30653325 |
| 51 | MP0005174_abnormal_tail_pigmentation | 1.28036866 |
| 52 | MP0005310_abnormal_salivary_gland | 1.21232300 |
| 53 | MP0004381_abnormal_hair_follicle | 1.17858604 |
| 54 | MP0002009_preneoplasia | 1.12540613 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.08104673 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.06635927 |
| 57 | MP0002132_abnormal_respiratory_system | 1.03844580 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.03423050 |
| 59 | MP0003303_peritoneal_inflammation | 0.98980687 |
| 60 | MP0002693_abnormal_pancreas_physiology | 0.98612699 |
| 61 | MP0005365_abnormal_bile_salt | 0.97903662 |
| 62 | MP0009278_abnormal_bone_marrow | 0.97005343 |
| 63 | MP0010352_gastrointestinal_tract_polyps | 0.96833169 |
| 64 | MP0005166_decreased_susceptibility_to | 0.96301784 |
| 65 | MP0009764_decreased_sensitivity_to | 0.95857012 |
| 66 | MP0002019_abnormal_tumor_incidence | 0.95668476 |
| 67 | MP0001851_eye_inflammation | 0.95646301 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 0.94145340 |
| 69 | MP0001666_abnormal_nutrient_absorption | 0.93369645 |
| 70 | MP0010234_abnormal_vibrissa_follicle | 0.87854628 |
| 71 | MP0004510_myositis | 0.87715597 |
| 72 | MP0003448_altered_tumor_morphology | 0.87320009 |
| 73 | MP0006054_spinal_hemorrhage | 0.86999886 |
| 74 | MP0004883_abnormal_blood_vessel | 0.86126598 |
| 75 | MP0000604_amyloidosis | 0.86119898 |
| 76 | MP0009840_abnormal_foam_cell | 0.84107375 |
| 77 | MP0003828_pulmonary_edema | 0.84023572 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.83597333 |
| 79 | MP0002877_abnormal_melanocyte_morpholog | 0.83217054 |
| 80 | MP0009763_increased_sensitivity_to | 0.82489100 |
| 81 | MP0003191_abnormal_cellular_cholesterol | 0.82375334 |
| 82 | MP0003183_abnormal_peptide_metabolism | 0.80676320 |
| 83 | MP0005023_abnormal_wound_healing | 0.80633283 |
| 84 | MP0000609_abnormal_liver_physiology | 0.78811441 |
| 85 | MP0000477_abnormal_intestine_morphology | 0.77820178 |
| 86 | MP0003690_abnormal_glial_cell | 0.77277787 |
| 87 | MP0003075_altered_response_to | 0.76545933 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 0.75765768 |
| 89 | MP0003943_abnormal_hepatobiliary_system | 0.75345985 |
| 90 | MP0003693_abnormal_embryo_hatching | 0.75024466 |
| 91 | MP0002095_abnormal_skin_pigmentation | 0.74227674 |
| 92 | MP0000569_abnormal_digit_pigmentation | 0.70144842 |
| 93 | MP0005083_abnormal_biliary_tract | 0.70110593 |
| 94 | MP0001663_abnormal_digestive_system | 0.69523920 |
| 95 | MP0008004_abnormal_stomach_pH | 0.67796164 |
| 96 | MP0009643_abnormal_urine_homeostasis | 0.66780408 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.65852934 |
| 98 | MP0004264_abnormal_extraembryonic_tissu | 0.64846861 |
| 99 | MP0005390_skeleton_phenotype | 0.64649319 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.63902674 |
| 101 | MP0000015_abnormal_ear_pigmentation | 0.63868113 |
| 102 | MP0001191_abnormal_skin_condition | 0.63273047 |
| 103 | MP0000249_abnormal_blood_vessel | 0.63105333 |
| 104 | MP0005164_abnormal_response_to | 0.62229478 |
| 105 | MP0005220_abnormal_exocrine_pancreas | 0.61702772 |
| 106 | MP0000343_altered_response_to | 0.60642365 |
| 107 | MP0009379_abnormal_foot_pigmentation | 0.60003605 |
| 108 | MP0003868_abnormal_feces_composition | 0.59754128 |
| 109 | MP0003806_abnormal_nucleotide_metabolis | 0.59049911 |
| 110 | MP0002998_abnormal_bone_remodeling | 0.58968339 |
| 111 | MP0000598_abnormal_liver_morphology | 0.58207371 |
| 112 | MP0001764_abnormal_homeostasis | 0.57843366 |
| 113 | MP0001216_abnormal_epidermal_layer | 0.57701621 |
| 114 | MP0002928_abnormal_bile_duct | 0.56641932 |
| 115 | MP0001765_abnormal_ion_homeostasis | 0.56536350 |
| 116 | MP0001348_abnormal_lacrimal_gland | 0.55564888 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.55484870 |
| 118 | MP0003795_abnormal_bone_structure | 0.55195076 |
| 119 | MP0008057_abnormal_DNA_replication | 0.54540016 |
| 120 | MP0005085_abnormal_gallbladder_physiolo | 0.53180864 |
| 121 | MP0003045_fibrosis | 0.52996555 |
| 122 | MP0008874_decreased_physiological_sensi | 0.51549146 |
| 123 | MP0000367_abnormal_coat/_hair | 0.49744690 |
| 124 | MP0002254_reproductive_system_inflammat | 0.49272148 |
| 125 | MP0005381_digestive/alimentary_phenotyp | 0.47435831 |
| 126 | MP0009115_abnormal_fat_cell | 0.41942722 |
| 127 | MP0004130_abnormal_muscle_cell | 0.41841378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.86165206 |
| 2 | Abnormality of T cell number (HP:0011839) | 5.69042485 |
| 3 | IgM deficiency (HP:0002850) | 5.10866042 |
| 4 | Recurrent bronchitis (HP:0002837) | 5.06868880 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.99899129 |
| 6 | Abnormality of T cells (HP:0002843) | 4.73873774 |
| 7 | Severe combined immunodeficiency (HP:0004430) | 4.46478816 |
| 8 | Chronic otitis media (HP:0000389) | 4.38261886 |
| 9 | Combined immunodeficiency (HP:0005387) | 4.14836436 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.10215920 |
| 11 | Eczematoid dermatitis (HP:0000976) | 3.98580866 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.90553360 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.90258628 |
| 14 | Recurrent viral infections (HP:0004429) | 3.83295523 |
| 15 | Lymphopenia (HP:0001888) | 3.82912767 |
| 16 | IgG deficiency (HP:0004315) | 3.82299437 |
| 17 | Pustule (HP:0200039) | 3.77796556 |
| 18 | Myositis (HP:0100614) | 3.77059374 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.77045651 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.77045651 |
| 21 | Thrombocytosis (HP:0001894) | 3.77041320 |
| 22 | Abnormality of T cell physiology (HP:0011840) | 3.76148783 |
| 23 | Chronic diarrhea (HP:0002028) | 3.73256438 |
| 24 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.67747122 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 3.62842823 |
| 26 | Thyroiditis (HP:0100646) | 3.58481204 |
| 27 | Autoimmune hemolytic anemia (HP:0001890) | 3.47475475 |
| 28 | Stomatitis (HP:0010280) | 3.45306137 |
| 29 | Recurrent abscess formation (HP:0002722) | 3.29307310 |
| 30 | Nasal polyposis (HP:0100582) | 3.26495424 |
| 31 | B lymphocytopenia (HP:0010976) | 3.26320203 |
| 32 | Abnormality of B cell number (HP:0010975) | 3.26320203 |
| 33 | Agammaglobulinemia (HP:0004432) | 3.23803704 |
| 34 | Autoimmune thrombocytopenia (HP:0001973) | 3.22888037 |
| 35 | Abnormality of eosinophils (HP:0001879) | 3.18988041 |
| 36 | Bronchitis (HP:0012387) | 3.10944021 |
| 37 | Hypoplasia of the thymus (HP:0000778) | 3.10495958 |
| 38 | Vasculitis (HP:0002633) | 3.09478703 |
| 39 | Prolonged bleeding time (HP:0003010) | 3.07597952 |
| 40 | Recurrent sinusitis (HP:0011108) | 3.07129995 |
| 41 | Gastrointestinal stroma tumor (HP:0100723) | 3.07015669 |
| 42 | Abnormality of the nasal mucosa (HP:0000433) | 3.05163201 |
| 43 | IgA deficiency (HP:0002720) | 3.04409210 |
| 44 | Spontaneous hematomas (HP:0007420) | 2.99706063 |
| 45 | Abnormality of the fingertips (HP:0001211) | 2.90684136 |
| 46 | Leukocytosis (HP:0001974) | 2.89467336 |
| 47 | Meningitis (HP:0001287) | 2.89111160 |
| 48 | Inflammation of the large intestine (HP:0002037) | 2.79581802 |
| 49 | Lymphoma (HP:0002665) | 2.79323290 |
| 50 | Epistaxis (HP:0000421) | 2.77113536 |
| 51 | Recurrent skin infections (HP:0001581) | 2.76115488 |
| 52 | Gastrointestinal inflammation (HP:0004386) | 2.71709062 |
| 53 | Recurrent bacterial skin infections (HP:0005406) | 2.62647984 |
| 54 | Joint swelling (HP:0001386) | 2.62138147 |
| 55 | Aplastic anemia (HP:0001915) | 2.55438129 |
| 56 | Urticaria (HP:0001025) | 2.55075750 |
| 57 | Pulmonary embolism (HP:0002204) | 2.54401537 |
| 58 | Hemoptysis (HP:0002105) | 2.49776237 |
| 59 | Petechiae (HP:0000967) | 2.49742003 |
| 60 | Poikiloderma (HP:0001029) | 2.49621787 |
| 61 | Gangrene (HP:0100758) | 2.49131728 |
| 62 | Interstitial pulmonary disease (HP:0006530) | 2.48889165 |
| 63 | Increased IgE level (HP:0003212) | 2.46574096 |
| 64 | Mediastinal lymphadenopathy (HP:0100721) | 2.46239610 |
| 65 | Granulocytopenia (HP:0001913) | 2.42334739 |
| 66 | Eosinophilia (HP:0001880) | 2.41780158 |
| 67 | Encephalitis (HP:0002383) | 2.41537272 |
| 68 | Anorexia (HP:0002039) | 2.41333001 |
| 69 | Abnormality of glycolipid metabolism (HP:0010969) | 2.40635213 |
| 70 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.40635213 |
| 71 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.40635213 |
| 72 | Periodontitis (HP:0000704) | 2.39486458 |
| 73 | Orchitis (HP:0100796) | 2.34890331 |
| 74 | Retrobulbar optic neuritis (HP:0100654) | 2.32825766 |
| 75 | Optic neuritis (HP:0100653) | 2.32825766 |
| 76 | Hypochromic anemia (HP:0001931) | 2.32821811 |
| 77 | Chronic sinusitis (HP:0011109) | 2.32292524 |
| 78 | Increased IgM level (HP:0003496) | 2.27909498 |
| 79 | Abnormality of the pleura (HP:0002103) | 2.27239683 |
| 80 | Basal cell carcinoma (HP:0002671) | 2.26926948 |
| 81 | Hypergammaglobulinemia (HP:0010702) | 2.23066852 |
| 82 | Cheilitis (HP:0100825) | 2.22116921 |
| 83 | Gastrointestinal infarctions (HP:0005244) | 2.21478379 |
| 84 | Arterial thrombosis (HP:0004420) | 2.21354402 |
| 85 | Gingival bleeding (HP:0000225) | 2.20972444 |
| 86 | Abnormal platelet volume (HP:0011876) | 2.19517674 |
| 87 | Emphysema (HP:0002097) | 2.17942918 |
| 88 | Colitis (HP:0002583) | 2.16154446 |
| 89 | Obstructive lung disease (HP:0006536) | 2.14792536 |
| 90 | Chronic obstructive pulmonary disease (HP:0006510) | 2.14792536 |
| 91 | Microcytic anemia (HP:0001935) | 2.12410016 |
| 92 | Increased cerebral lipofuscin (HP:0011813) | 2.10499368 |
| 93 | Osteomyelitis (HP:0002754) | 2.10429585 |
| 94 | Restrictive lung disease (HP:0002091) | 2.09806080 |
| 95 | Recurrent otitis media (HP:0000403) | 2.09244664 |
| 96 | Pulmonary infiltrates (HP:0002113) | 2.09080031 |
| 97 | Verrucae (HP:0200043) | 2.07416583 |
| 98 | Papilloma (HP:0012740) | 2.07416583 |
| 99 | Chest pain (HP:0100749) | 2.07353509 |
| 100 | Glomerulopathy (HP:0100820) | 2.06462500 |
| 101 | Sepsis (HP:0100806) | 2.06008918 |
| 102 | Cellulitis (HP:0100658) | 2.02955454 |
| 103 | Keratoconjunctivitis sicca (HP:0001097) | 2.02546806 |
| 104 | Gingivitis (HP:0000230) | 2.01597083 |
| 105 | Ureteral stenosis (HP:0000071) | 2.01360929 |
| 106 | Slow saccadic eye movements (HP:0000514) | 2.00014019 |
| 107 | Amaurosis fugax (HP:0100576) | 1.99731598 |
| 108 | Increased serum ferritin (HP:0003281) | 1.99548886 |
| 109 | Skin ulcer (HP:0200042) | 1.98975778 |
| 110 | Abnormality of the prostate (HP:0008775) | 1.98556560 |
| 111 | Keratoconjunctivitis (HP:0001096) | 1.98473584 |
| 112 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.97873520 |
| 113 | Papilledema (HP:0001085) | 1.97873445 |
| 114 | Reticulocytopenia (HP:0001896) | 1.97586859 |
| 115 | Acute hepatic failure (HP:0006554) | 1.97517308 |
| 116 | Abnormality of macrophages (HP:0004311) | 1.97440135 |
| 117 | Neutropenia (HP:0001875) | 1.96742426 |
| 118 | Abnormal number of erythroid precursors (HP:0012131) | 1.96671680 |
| 119 | Purpura (HP:0000979) | 1.96325030 |
| 120 | Polyneuropathy (HP:0001271) | 1.95823149 |
| 121 | Ureteral obstruction (HP:0006000) | 1.95135615 |
| 122 | Arthralgia (HP:0002829) | 1.93074817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.22445680 |
| 2 | TXK | 4.62310027 |
| 3 | JAK3 | 3.27377111 |
| 4 | ZAP70 | 3.03007855 |
| 5 | IKBKE | 3.01120562 |
| 6 | FGFR4 | 2.95474683 |
| 7 | NLK | 2.67376582 |
| 8 | ITK | 2.58625115 |
| 9 | TYK2 | 2.54326263 |
| 10 | MAP3K14 | 2.45142382 |
| 11 | TEC | 2.27732144 |
| 12 | PRPF4B | 2.16353897 |
| 13 | TBK1 | 2.09623005 |
| 14 | IRAK4 | 2.07628354 |
| 15 | BTK | 2.02809786 |
| 16 | JAK1 | 2.00368426 |
| 17 | BLK | 1.91840492 |
| 18 | FGFR3 | 1.87486862 |
| 19 | GRK6 | 1.83066699 |
| 20 | STK10 | 1.80224142 |
| 21 | LCK | 1.68123240 |
| 22 | KIT | 1.67688997 |
| 23 | NME2 | 1.63455133 |
| 24 | SYK | 1.51169183 |
| 25 | TESK2 | 1.49985303 |
| 26 | CSK | 1.48494414 |
| 27 | MST4 | 1.47920326 |
| 28 | FLT3 | 1.37896922 |
| 29 | KDR | 1.31088406 |
| 30 | EEF2K | 1.24486846 |
| 31 | IKBKB | 1.24112750 |
| 32 | FGR | 1.22719461 |
| 33 | HCK | 1.21863115 |
| 34 | MAP3K13 | 1.19927276 |
| 35 | TGFBR2 | 1.19056889 |
| 36 | BMPR2 | 1.17603168 |
| 37 | CAMKK2 | 1.17302920 |
| 38 | ERN1 | 1.15061552 |
| 39 | LRRK2 | 1.09678432 |
| 40 | TGFBR1 | 1.09421576 |
| 41 | PKN2 | 1.04855234 |
| 42 | IRAK3 | 1.04778049 |
| 43 | ACVR1B | 0.97716500 |
| 44 | CHUK | 0.94854885 |
| 45 | PASK | 0.93400574 |
| 46 | MAP2K3 | 0.89795833 |
| 47 | JAK2 | 0.88281267 |
| 48 | LYN | 0.87977150 |
| 49 | TNK2 | 0.87971926 |
| 50 | EPHA3 | 0.87796622 |
| 51 | RPS6KA4 | 0.87429136 |
| 52 | MATK | 0.86919137 |
| 53 | TAOK3 | 0.86706258 |
| 54 | MAP3K1 | 0.85260386 |
| 55 | CAMKK1 | 0.84421459 |
| 56 | PRKCQ | 0.83579661 |
| 57 | CSF1R | 0.81933141 |
| 58 | HIPK2 | 0.81288042 |
| 59 | TAOK2 | 0.80890835 |
| 60 | MAP2K6 | 0.77298857 |
| 61 | GRK7 | 0.76235997 |
| 62 | MAP3K10 | 0.76229673 |
| 63 | MAP3K3 | 0.75492379 |
| 64 | EPHB1 | 0.75159545 |
| 65 | PIM1 | 0.74582818 |
| 66 | CLK1 | 0.72209211 |
| 67 | RPS6KB2 | 0.67014543 |
| 68 | PRKCH | 0.65859588 |
| 69 | MAP3K7 | 0.65134732 |
| 70 | BCKDK | 0.63994087 |
| 71 | IRAK1 | 0.61001856 |
| 72 | MARK3 | 0.60528533 |
| 73 | CDC42BPA | 0.59858223 |
| 74 | SIK2 | 0.57887240 |
| 75 | RIPK4 | 0.57876513 |
| 76 | SIK1 | 0.56975785 |
| 77 | FES | 0.55816420 |
| 78 | SCYL2 | 0.54635119 |
| 79 | TYRO3 | 0.53555978 |
| 80 | PIK3CG | 0.52546289 |
| 81 | MAP3K12 | 0.52028411 |
| 82 | MAPK11 | 0.50956441 |
| 83 | SMG1 | 0.50497578 |
| 84 | MAPK7 | 0.49717063 |
| 85 | SIK3 | 0.49250524 |
| 86 | MAPK12 | 0.48324603 |
| 87 | FGFR2 | 0.47699385 |
| 88 | PRKG2 | 0.47033459 |
| 89 | MARK2 | 0.46533537 |
| 90 | PDPK1 | 0.45798947 |
| 91 | TNIK | 0.44387429 |
| 92 | PDGFRB | 0.43615172 |
| 93 | TRPM7 | 0.42373373 |
| 94 | CDK9 | 0.40013569 |
| 95 | STK4 | 0.39575340 |
| 96 | TRIB3 | 0.39387120 |
| 97 | TESK1 | 0.37857568 |
| 98 | IGF1R | 0.36434676 |
| 99 | NEK9 | 0.36174420 |
| 100 | NEK6 | 0.35552795 |
| 101 | PDK1 | 0.35081953 |
| 102 | PTK6 | 0.34509473 |
| 103 | KSR2 | 0.33606162 |
| 104 | MAPK3 | 0.33263236 |
| 105 | MAP3K11 | 0.32865988 |
| 106 | FRK | 0.32782925 |
| 107 | MAP3K5 | 0.31938844 |
| 108 | MAP2K2 | 0.31588346 |
| 109 | TAOK1 | 0.30896139 |
| 110 | CDK6 | 0.30723768 |
| 111 | CDK4 | 0.30527939 |
| 112 | YES1 | 0.30123182 |
| 113 | RPS6KL1 | 0.29961805 |
| 114 | RPS6KC1 | 0.29961805 |
| 115 | TLK1 | 0.29457855 |
| 116 | EIF2AK3 | 0.28773140 |
| 117 | MELK | 0.28455777 |
| 118 | MAPK4 | 0.28185085 |
| 119 | MAPKAPK2 | 0.27940479 |
| 120 | PRKD2 | 0.27737778 |
| 121 | CDK12 | 0.27239485 |
| 122 | RET | 0.25773090 |
| 123 | FYN | 0.23837682 |
| 124 | NUAK1 | 0.22913797 |
| 125 | RPS6KA6 | 0.22239172 |
| 126 | PRKCD | 0.21042515 |
| 127 | INSR | 0.20397870 |
| 128 | TIE1 | 0.19646396 |
| 129 | ABL1 | 0.18031931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.72051282 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.10884182 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.77371505 |
| 4 | Measles_Homo sapiens_hsa05162 | 2.77342751 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.75868204 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.74116285 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.49912854 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.40641020 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.39493464 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.25749263 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.24873724 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.13986930 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.00567086 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.99774307 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.95994213 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.90161726 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.87362192 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.81616418 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.77305748 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.52320159 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.34124638 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.30585945 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29925828 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28484696 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.28158265 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27465095 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22749262 |
| 28 | Hepatitis B_Homo sapiens_hsa05161 | 1.17331858 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16526172 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13763740 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11171464 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10816293 |
| 33 | Protein export_Homo sapiens_hsa03060 | 1.08651608 |
| 34 | Hepatitis C_Homo sapiens_hsa05160 | 1.05963027 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05854708 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.03163026 |
| 37 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02690673 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99350653 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 0.98486358 |
| 40 | DNA replication_Homo sapiens_hsa03030 | 0.96360583 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93900816 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 0.92964733 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 0.92254391 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 0.92096512 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.91336766 |
| 46 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88463196 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.85905770 |
| 48 | Phagosome_Homo sapiens_hsa04145 | 0.85784812 |
| 49 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85338659 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84642118 |
| 51 | Base excision repair_Homo sapiens_hsa03410 | 0.84179259 |
| 52 | Asthma_Homo sapiens_hsa05310 | 0.81409103 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 0.81139009 |
| 54 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.80842739 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80503597 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.78823677 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78698245 |
| 58 | Malaria_Homo sapiens_hsa05144 | 0.78335731 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76451108 |
| 60 | Mismatch repair_Homo sapiens_hsa03430 | 0.75830474 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73980049 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72219516 |
| 63 | Tuberculosis_Homo sapiens_hsa05152 | 0.69466542 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68278240 |
| 65 | Thyroid cancer_Homo sapiens_hsa05216 | 0.66831222 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.65642148 |
| 67 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.65299811 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61666735 |
| 69 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60532936 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.58782178 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.57845622 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57547582 |
| 73 | RNA degradation_Homo sapiens_hsa03018 | 0.56275655 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56094284 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55245585 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55047834 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54804074 |
| 78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.53917485 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52923682 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52481269 |
| 81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51686547 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51003207 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50521834 |
| 84 | Spliceosome_Homo sapiens_hsa03040 | 0.49792460 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48773260 |
| 86 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48297427 |
| 87 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.48005551 |
| 88 | Salmonella infection_Homo sapiens_hsa05132 | 0.47726696 |
| 89 | Homologous recombination_Homo sapiens_hsa03440 | 0.47638038 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47542432 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45606410 |
| 92 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.44706478 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44456306 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.44039259 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43862106 |
| 96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41730942 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41124443 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40509578 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39801299 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39358610 |
| 101 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38817511 |
| 102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38664680 |
| 103 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38083395 |
| 104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37698365 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37603032 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37592370 |
| 107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33761080 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33444867 |
| 109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32390623 |
| 110 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.31672086 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.30879250 |
| 112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.30691653 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.30669373 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30070971 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29774798 |
| 116 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.29106690 |
| 117 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28613907 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28171134 |
| 119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27380079 |
| 120 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.27207257 |
| 121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.26876681 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26534042 |
| 123 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.26003527 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24663131 |
| 125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23048356 |
| 126 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.22689652 |
| 127 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.21895049 |
| 128 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.21119120 |
| 129 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20430204 |
| 130 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20361743 |
| 131 | Prostate cancer_Homo sapiens_hsa05215 | 0.19300274 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.17742020 |
| 133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.17591678 |

